Skip to main content
Yixintang Pharmaceutical Group Co., Ltd. logo

Yixintang Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002727 ISIN · CNE100001WJ8 LEI · 300300NE1YJT00E9JD69 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,825 across all filing types
Latest filing 2025-11-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002727

About Yixintang Pharmaceutical Group Co., Ltd.

https://www.hx8886.com

Yixintang Pharmaceutical Group Co., Ltd. operates an extensive network of retail pharmacies providing a broad spectrum of healthcare products and services. The company specializes in the distribution of Western pharmaceuticals, traditional Chinese medicine (TCM), medical equipment, and health supplements. Its operational model integrates physical storefronts with digital platforms to facilitate online-to-offline (O2O) services, including prescription fulfillment and health consultations. Key offerings include chronic disease management, professional pharmaceutical advice, and a diverse inventory of over-the-counter (OTC) medications. The company focuses on community-based health accessibility, utilizing a robust supply chain to ensure product quality and availability across its service regions.

Recent filings

Filing Released Lang Actions
关于公司2026年度与云南国鹤药业有限公司日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from a company about its expected related party transactions for the upcoming fiscal year 2026 with a specific related party, including transaction amounts, pricing principles, and approvals by the board and independent directors. It includes explanations of the related party, the nature of the transactions, and the impact on the company. The document is not a financial report, earnings release, or audit report, but rather a regulatory announcement about anticipated related party transactions. It is not a short notice or a report publication announcement but a substantive disclosure about related party transactions as required by stock exchange rules. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-11-20 Chinese
关于公司及子公司2026年向相关银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 一心堂药业集团股份有限公司 regarding the company's and its subsidiaries' application for a comprehensive credit line from various banks for the year 2026. It details the credit limits, banks involved, purposes of the credit, and guarantees. The document includes board meeting resolutions and independent directors' opinions approving the credit application. There is no financial statement or detailed financial analysis presented, nor is it a report or transcript. The content is focused on financing activities and credit facilities. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about financing arrangements, not just a brief announcement or regulatory filing.
2025-11-20 Chinese
互动易平台信息发布及回复内部审核制度
Governance Information Classification · 95% confidence The document is titled as an internal management system for information disclosure and investor interaction on the Shenzhen Stock Exchange's interactive platform. It outlines rules and procedures for communication with investors, content requirements, internal management, and compliance with regulatory guidelines. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, or any other specific event. The document is a governance-related internal policy document aimed at improving company governance and investor relations. Therefore, it fits best under Governance Information (CGR). The document length is under 5,000 characters, but it is not an announcement of a report publication; it is a substantive governance policy document.
2025-11-20 Chinese
关于公司向关联方租赁房产的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company regarding a related-party transaction involving leasing property from a related party. It includes details of the transaction, approvals by the board and independent directors, and mentions the need for shareholder meeting approval. The document is relatively short (2045 characters) and is structured as a formal announcement rather than a detailed financial report. It does not contain financial statements or detailed financial analysis. It is not an annual or interim report, earnings release, or audit report. It is not a regulatory filing in the sense of officer certifications or compliance documents. It is a specific announcement about a related-party transaction, which is typically categorized under Regulatory Filings (RNS) as it does not fit other categories like Capital/Financing Update or Management Reports. Therefore, the best classification is Regulatory Filings (RNS).
2025-11-20 Chinese
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is titled '董事、高级管理人员薪酬管理制度' which translates to 'Remuneration Management System for Directors and Senior Management'. It details the principles, structure, management, adjustment, and implementation of remuneration for the company's directors and senior management. It references relevant laws and company governance but does not contain financial statements or performance data. The content is focused on remuneration policies and management rather than actual compensation figures or disclosures typically found in remuneration reports. Therefore, it fits the category of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2025-11-20 Chinese
关于公司股东阮鸿献先生部分股票质押融资到期还款解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the repayment and release of pledged shares by a major shareholder. It details the number of shares pledged, the release of the pledge upon repayment, and risk disclosures related to the pledged shares. The document includes tables with shareholding and pledge details and is signed by the company's board. There is no financial statement, earnings data, or management discussion. The content is focused on a shareholder's stock pledge financing and its release, which is a capital/financing update rather than a full financial report or regulatory filing. The document length is short (1631 characters), but it contains substantive information about financing activity, not just a notice of report publication or certification. Therefore, the best fitting category is Capital/Financing Update (CAP).
2025-11-20 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.